U.S. payers are warming up to covering digital therapeutics | Strategic Insight | Multichannel Payer Marketing Study 2020
Multichannel Payer Marketing 2020 is aimed to understand how and where U.S. payers obtain information for formulary decision-making, specifically using digital channels in addition to traditional methods, pinpointing unmet needs and determining how pharmas’ can better engage these key customers.
Questions answered in this report:
- What does the digital therapeutics landscape look like for U.S. payers, physicians, and consumers?
- How open are U.S. P&T committee members to covering DTx tools?
- How does openness towards digital therapeutics change with coverage plans?
